Intrexon reported $-0.1 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
Amgen USD 6.45 0.16 Sep/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.67 0.3 Sep/2026
MacroGenics USD 0.31 0.89 Jun/2026
MannKind USD -0.01 0 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Thermo Fisher Scientific USD 5.18 0.86 Sep/2026
Veracyte USD 0.51 0.03 Sep/2026
Xencor USD 0.5 0.79 Sep/2026